TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Weekly Paclitaxel, Carboplatin Safer For Advanced Lung Cancer, Study Finds August 31, 2001
TCL Archive In Brief: Unsolicited Proposals ‘Very Valuable,” DeVita Says, Asks Investigators To Keep Channel Open April 18, 1975